37 results
Thumbnail

D2.138 - Type 3 cytokine - dependent E3 epithelial programming is driven by a novel transcriptional regulator that impacts airway barrier integrity in asthma

Thumbnail

D2.142 - Longitudinal Airway Immune Responses to Respiratory Viruses in Asthmatic and Atopic Children

Thumbnail

D2.146 - Neuropsychiatric events associated with montelukast in children: a systematic review

Thumbnail

D2.135 - Preventive counseling regarding the risk factors for individuals with asthma or chronic obstructive pulmonary disease

Thumbnail

D2.136 - Association Between Serum 25-Hydroxyvitamin D Levels and Asthma Severity in Preschool Children

Thumbnail

D2.137 - Association of GLP-1 Receptor Agonists with Asthma Incidence among Patients with Obesity

Thumbnail

D2.139 - Atypical Presentation of House Dust Mite–Induced Atopic Asthma in an Adolescent Girl: A Case Report from a Remote Region of Kyrgyzstan

Thumbnail

D2.141 - Predictors of inpatient admission amongst children presenting with acute asthma exacerbation: influence of the patient’s prior clinical profile

Thumbnail

D2.143 - Cypress pollen as a major aeroallergen in paediatric respiratory allergy: experience in Gaziantep, south-eastern Türkiye

Thumbnail

D2.144 - Bronchial Inflammation and Lung Function in Children with Asthma and Allergic Rhinitis: The Contribution of FeNO and Spirometry

Thumbnail

D2.145 - Parental Recognition and Consistency of Noisy Breathing Reports: Treatment and Symptom Associations

Thumbnail

D2.148 - Exploring the Role of Bacterial Lysate OM-85 on Immune Mechanisms in Type 2-high Asthma

Thumbnail

D2.449 - Patients with Inadequately Controlled CRSwNP and Blood Eosinophil Count ≥150 cells/µL Experience Benefit with Depemokimab: An Analysis of Data from the Integrated ANCHOR-1/-2 Studies

Thumbnail

D2.447 - Phenotyping of Chronic T2 Inflammatory Diseases of the Nose and Paranasal Sinuses and the Algorithm for Biologic Therapy Selection

Thumbnail

D2.448 - Recommendations on Patient Education for Biological Therapy in CRSwNP – An EAACI Position Paper

Thumbnail

D2.450 - EUFOREA/EPOS Criteria Applied to a Diverse CRSwNP Cohort: Post Hoc Findings from Twice-Yearly depemokimab ANCHOR-1/-2 trials

Thumbnail

D2.451 - Real-life upper and lower airway outcomes of long-term dupilumab treatment in patients with severe chronic rhinosinusitis with nasal polyps

Thumbnail

D2.452 - Real-World Trends in the Epidemiology and Burden of Chronic Rhinosinusitis with Nasal Polyps Over Time in Germany Reveal Increasing Prevalence and Low Biologic Use

Thumbnail

D2.453 - Olfactory outcomes of dupilumab in patients with CRSwNP: A real-world prospective study

Thumbnail

D2.455 - Does Biological Therapy Modify NSAID Hypersensitivity? Experience with Omalizumab and Mepolizumab in Patients with Asthma and Nasal Polyps with N-ERD